| GO ID | GO name | Interaction type | Reference |
|---|---|---|---|
| GO:0000084 | Mitotic s phase | Affects phenotype | PMID:31601247 |
| GO:0000086 | G2/m transition of mitotic cell cycle | Affects phenotype | PMID:31601247 |
| GO:0000212 | Meiotic spindle organization | Decreases phenotype | PMID:29102535 |
| GO:0000266 | Mitochondrial fission | Increases phenotype | PMID:34023961 |
| GO:0000423 | Mitophagy | Increases phenotype | PMID:39929295 |
| GO:0000737 | Dna catabolic process, endonucleolytic | Increases phenotype | PMID:37601897 |
| GO:0001541 | Ovarian follicle development | Decreases phenotype | PMID:31424294 |
| GO:0001547 | Antral ovarian follicle growth | Increases phenotype | PMID:31424294 |
| GO:0001556 | Oocyte maturation | Decreases phenotype | PMID:29102535 |
| GO:0001774 | Microglial cell activation | Increases phenotype | PMID:38266696 |
| GO:0002157 | Positive regulation of thyroid hormone mediated signaling pathway | Increases phenotype | PMID:29146198 |
| GO:0002281 | Macrophage activation involved in immune response | Increases phenotype | PMID:32044397 |
| GO:0003093 | Regulation of glomerular filtration | Increases phenotype | PMID:33755180 |
| GO:0003300 | Cardiac muscle hypertrophy | Increases phenotype | PMID:37611474 |
| GO:0004000 | Adenosine deaminase activity | Increases phenotype | PMID:39577800 |
| GO:0004112 | Cyclic-nucleotide phosphodiesterase activity | Increases phenotype | PMID:39577800 |
| GO:0004364 | Glutathione transferase activity | Decreases phenotype | PMID:37601897 |
| GO:0004457 | Lactate dehydrogenase activity | Increases phenotype | PMID:37601897 |
| GO:0004602 | Glutathione peroxidase activity | Decreases phenotype | PMID:31453682; PMID:37601897 |
| GO:0004722 | Protein serine/threonine phosphatase activity | Increases phenotype | PMID:34023961 |
| GO:0004784 | Superoxide dismutase activity | Decreases phenotype | PMID:31424294; PMID:31453682; PMID:37601897; PMID:39059691 |
| GO:0005739 | Mitochondrion | Increases phenotype | PMID:34023961 |
| GO:0005757 | Mitochondrial permeability transition pore complex | Decreases phenotype | PMID:34474090 |
| GO:0005911 | Cell-cell junction | Decreases phenotype | PMID:28808208 |
| GO:0006089 | Lactate metabolic process | Affects phenotype | PMID:34147605 |
| GO:0006094 | Gluconeogenesis | Affects phenotype | PMID:31121516 |
| GO:0006119 | Oxidative phosphorylation | Decreases phenotype | PMID:39929295 |
| GO:0006163 | Purine nucleotide metabolic process | Affects phenotype | PMID:38685157 |
| GO:0006306 | Dna methylation | Affects phenotype | PMID:36473650 |
| GO:0006338 | Chromatin remodeling | Increases phenotype | PMID:33916708; PMID:38685157 |
| GO:0006518 | Peptide metabolic process | Affects phenotype | PMID:38685157 |
| GO:0006520 | Amino acid metabolic process | Affects phenotype | PMID:38685157 |
| GO:0006523 | Alanine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0006537 | Glutamate biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0006542 | Glutamine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0006545 | Glycine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0006568 | Tryptophan metabolic process | Affects phenotype | PMID:38266696 |
| GO:0006571 | Tyrosine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0006626 | Protein targeting to mitochondrion | Affects phenotype | PMID:34023961 |
| GO:0006629 | Lipid metabolic process | Affects phenotype | PMID:31820560; PMID:36632902 |
| GO:0006631 | Fatty acid metabolic process | Affects phenotype | PMID:36632902; PMID:38685157 |
| GO:0006633 | Fatty acid biosynthetic process | Affects phenotype | PMID:30145421 |
| GO:0006641 | Triglyceride metabolic process | Affects phenotype | PMID:36632902 |
| GO:0006646 | Phosphatidylethanolamine biosynthetic process | Affects phenotype | PMID:31453682 |
| GO:0006653 | 1,2-diacyl-sn-glycero-3-phosphocholine metabolic process | Affects phenotype | PMID:38685157 |
| GO:0006659 | Phosphatidylserine biosynthetic process | Decreases phenotype | PMID:31453682 |
| GO:0006670 | Sphingosine metabolic process | Affects phenotype | PMID:38685157 |
| GO:0006686 | Sphingomyelin biosynthetic process | Decreases phenotype | PMID:31453682 |
| GO:0006693 | Prostaglandin metabolic process | Affects phenotype | PMID:38685157 |
| GO:0006701 | Progesterone biosynthetic process | Decreases phenotype | PMID:31424294 |
| GO:0006749 | Glutathione metabolic process | Increases phenotype | PMID:28259788; PMID:31875995; PMID:39736419 |
| GO:0006750 | Glutathione biosynthetic process | Decreases phenotype | PMID:31453682 |
| GO:0006754 | Atp biosynthetic process | Decreases phenotype | PMID:29079494 |
| GO:0006874 | Cellular calcium ion homeostasis | Affects phenotype | PMID:34023961 |
| GO:0006915 | Apoptotic process | Increases phenotype | PMID:31453682; PMID:35387338; PMID:37601897; PMID:39577800 |
| GO:0006954 | Inflammatory response | Increases phenotype | PMID:37601897 |
| GO:0006974 | Cellular response to dna damage stimulus | Increases phenotype | PMID:26916392; PMID:29102535; PMID:31207516; PMID:32244372 |
| GO:0006979 | Response to oxidative stress | Affects phenotype | PMID:34619205 |
| GO:0007056 | Spindle assembly involved in female meiosis | Decreases phenotype | PMID:33476676 |
| GO:0007204 | Positive regulation of cytosolic calcium ion concentration | Increases phenotype | PMID:30195206 |
| GO:0007283 | Spermatogenesis | Decreases phenotype | PMID:29940534; PMID:35803362; PMID:37601897 |
| GO:0008152 | Metabolic process | Affects phenotype | PMID:34774955 |
| GO:0008202 | Steroid metabolic process | Affects phenotype | PMID:24563381; PMID:38685157 |
| GO:0008203 | Cholesterol metabolic process | Affects phenotype | PMID:36632902; PMID:37601897; PMID:38685157 |
| GO:0008206 | Bile acid metabolic process | Affects phenotype | PMID:36632902 |
| GO:0008210 | Estrogen metabolic process | Increases phenotype | PMID:24563381; PMID:33753083 |
| GO:0008219 | Cell death | Increases phenotype | PMID:35387338 |
| GO:0008234 | Cysteine-type peptidase activity | Increases phenotype | PMID:33312107; PMID:33916708 |
| GO:0008283 | Cell population proliferation | Increases phenotype | PMID:26916392; PMID:28616630; PMID:28808208; PMID:28808208; PMID:39577800 |
| GO:0008284 | Positive regulation of cell population proliferation | Increases phenotype | PMID:28591870; PMID:29146198; PMID:30099086; PMID:30195206; PMID:30196065; PMID:32023790 |
| GO:0008285 | Negative regulation of cell population proliferation | Increases phenotype | PMID:30196065; PMID:32023790; PMID:32044397; PMID:32763284; PMID:34831106; PMID:36534918 |
| GO:0008584 | Male gonad development | Affects phenotype | PMID:37164221 |
| GO:0008652 | Amino acid biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0009070 | Serine family amino acid biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0009085 | Lysine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0009088 | Threonine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0009094 | L-phenylalanine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0009097 | Isoleucine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0009098 | Leucine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0009099 | Valine biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0009308 | Amine metabolic process | Affects phenotype | PMID:38685157 |
| GO:0009437 | Carnitine metabolic process | Affects phenotype | PMID:38685157 |
| GO:0009696 | Salicylic acid metabolic process | Affects phenotype | PMID:38685157 |
| GO:0009820 | Alkaloid metabolic process | Affects phenotype | PMID:38685157 |
| GO:0010424 | Dna methylation on cytosine within a cg sequence | Affects phenotype | PMID:31601247; PMID:38898774 |
| GO:0010825 | Positive regulation of centrosome duplication | Increases phenotype | PMID:27998958 |
| GO:0010942 | Positive regulation of cell death | Increases phenotype | PMID:30196065; PMID:32023790; PMID:34831106 |
| GO:0015936 | Coenzyme a metabolic process | Affects phenotype | PMID:38685157 |
| GO:0015943 | Formate biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0016042 | Lipid catabolic process | Increases phenotype | PMID:31424294; PMID:31453682 |
| GO:0016344 | Meiotic chromosome movement towards spindle pole | Decreases phenotype | PMID:29102535 |
| GO:0016477 | Cell migration | Increases phenotype | PMID:28808208 |
| GO:0016887 | Atp hydrolysis activity | Decreases phenotype | PMID:29079494 |
| GO:0018158 | Protein oxidation | Increases phenotype | PMID:29079494 |
| GO:0019413 | Acetate biosynthetic process | Affects phenotype | PMID:31121516 |
| GO:0019530 | Taurine metabolic process | Affects phenotype | PMID:38685157 |
| GO:0019674 | Nad metabolic process | Affects phenotype | PMID:38266696 |
| GO:0019695 | Choline metabolic process | Affects phenotype | PMID:38685157 |
| GO:0019752 | Carboxylic acid metabolic process | Affects phenotype | PMID:38685157 |
| GO:0019858 | Cytosine metabolic process | Affects phenotype | PMID:38685157 |
| GO:0030182 | Neuron differentiation | Decreases phenotype | PMID:39577800 |
| GO:0030861 | Negative regulation of polarized epithelial cell differentiation | Increases phenotype | PMID:35278557 |
| GO:0032148 | Activation of protein kinase b activity | Increases phenotype | PMID:30195206 |
| GO:0032776 | Dna methylation on cytosine | Increases phenotype | PMID:30196065 |
| GO:0033148 | Positive regulation of intracellular estrogen receptor signaling pathway | Increases phenotype | PMID:31388671; PMID:34831106 |
| GO:0033566 | Gamma-tubulin complex localization | Affects phenotype | PMID:29102535 |
| GO:0034063 | Stress granule assembly | Increases phenotype | PMID:33431410 |
| GO:0034440 | Lipid oxidation | Increases phenotype | PMID:28259788; PMID:29940534; PMID:36632902; PMID:39577800 |
| GO:0035264 | Multicellular organism growth | Increases phenotype | PMID:33755180 |
| GO:0035640 | Exploration behavior | Decreases phenotype | PMID:38266696 |
| GO:0035794 | Positive regulation of mitochondrial membrane permeability | Increases phenotype | PMID:30196065 |
| GO:0036124 | Histone h3-k9 trimethylation | Decreases phenotype | PMID:29102535 |
| GO:0036151 | Phosphatidylcholine acyl-chain remodeling | Affects phenotype | PMID:31453682 |
| GO:0036152 | Phosphatidylethanolamine acyl-chain remodeling | Affects phenotype | PMID:31453682 |
| GO:0036343 | Psychomotor behavior | Affects phenotype | PMID:39577800 |
| GO:0040029 | Epigenetic regulation of gene expression | Affects phenotype | PMID:38338858 |
| GO:0040038 | Polar body extrusion after meiotic divisions | Decreases phenotype | PMID:29102535 |
| GO:0042048 | Olfactory behavior | Affects phenotype | PMID:36706583 |
| GO:0042116 | Macrophage activation | Increases phenotype | PMID:34147605 |
| GO:0042127 | Regulation of cell population proliferation | Affects phenotype | PMID:30196065 |
| GO:0042158 | Lipoprotein biosynthetic process | Increases phenotype | PMID:37837293 |
| GO:0042278 | Purine nucleoside metabolic process | Affects phenotype | PMID:38685157 |
| GO:0042428 | Serotonin metabolic process | Affects phenotype | PMID:38266696 |
| GO:0042431 | Indole metabolic process | Affects phenotype | PMID:38685157 |
| GO:0042701 | Progesterone secretion | Affects phenotype | PMID:37182577 |
| GO:0042733 | Embryonic digit morphogenesis | Affects phenotype | PMID:38898774 |
| GO:0043065 | Positive regulation of apoptotic process | Increases phenotype | PMID:35940389; PMID:38134982 |
| GO:0043974 | Histone h3-k27 acetylation | Affects phenotype | PMID:29102535; PMID:38685157 |
| GO:0044030 | Regulation of dna methylation | Affects phenotype | PMID:38338858 |
| GO:0044237 | Cellular metabolic process | Increases phenotype | PMID:31601247; PMID:31812737; PMID:32244372; PMID:32976987; PMID:33916708; PMID:34023961; PMID:34474090; PMID:35457000; PMID:36674557; PMID:39736419 |
| GO:0044319 | Wound healing, spreading of cells | Increases phenotype | PMID:31601247 |
| GO:0045333 | Cellular respiration | Decreases phenotype | PMID:39929295 |
| GO:0045444 | Fat cell differentiation | Affects phenotype | PMID:34186270 |
| GO:0045792 | Negative regulation of cell size | Increases phenotype | PMID:35803362 |
| GO:0045931 | Positive regulation of mitotic cell cycle | Increases phenotype | PMID:32023790 |
| GO:0046034 | Atp metabolic process | Affects phenotype | PMID:33312107; PMID:34023961; PMID:39929295 |
| GO:0046083 | Adenine metabolic process | Affects phenotype | PMID:38685157 |
| GO:0046085 | Adenosine metabolic process | Affects phenotype | PMID:38685157 |
| GO:0046209 | Nitric oxide metabolic process | Affects phenotype | PMID:39577800 |
| GO:0046323 | Glucose import | Increases phenotype | PMID:34147605 |
| GO:0046449 | Creatinine metabolic process | Affects phenotype | PMID:38685157 |
| GO:0046474 | Glycerophospholipid biosynthetic process | Increases phenotype | PMID:31453682 |
| GO:0046483 | Heterocycle metabolic process | Affects phenotype | PMID:38685157 |
| GO:0046512 | Sphingosine biosynthetic process | Increases phenotype | PMID:31453682 |
| GO:0046513 | Ceramide biosynthetic process | Increases phenotype | PMID:31453682 |
| GO:0046621 | Negative regulation of organ growth | Increases phenotype | PMID:35278557 |
| GO:0048143 | Astrocyte activation | Increases phenotype | PMID:39577800 |
| GO:0050765 | Negative regulation of phagocytosis | Increases phenotype | PMID:32044397 |
| GO:0050768 | Negative regulation of neurogenesis | Increases phenotype | PMID:36706583 |
| GO:0050898 | Nitrile metabolic process | Affects phenotype | PMID:38685157 |
| GO:0051310 | Metaphase plate congression | Decreases phenotype | PMID:33476676 |
| GO:0051646 | Mitochondrion localization | Affects phenotype | PMID:39929295 |
| GO:0051881 | Regulation of mitochondrial membrane potential | Affects phenotype | PMID:39929295 |
| GO:0051899 | Membrane depolarization | Affects phenotype | PMID:39929295 |
| GO:0052838 | Thiazole metabolic process | Affects phenotype | PMID:38685157 |
| GO:0055074 | Calcium ion homeostasis | Affects phenotype | PMID:26916392; PMID:28858478 |
| GO:0060011 | Sertoli cell proliferation | Affects phenotype | PMID:37601897 |
| GO:0060073 | Micturition | Increases phenotype | PMID:33755180 |
| GO:0061370 | Testosterone biosynthetic process | Increases phenotype | PMID:28482050; PMID:31424294; PMID:33753083; PMID:37601897 |
| GO:0070059 | Intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | Increases phenotype | PMID:35940389 |
| GO:0070091 | Glucagon secretion | Decreases phenotype | PMID:36674557 |
| GO:0070189 | Kynurenine metabolic process | Affects phenotype | PMID:38266696 |
| GO:0070374 | Positive regulation of erk1 and erk2 cascade | Increases phenotype | PMID:30195206 |
| GO:0070994 | Detection of oxidative stress | Increases phenotype | PMID:35940389; PMID:37601897 |
| GO:0071557 | Histone h3-k27 demethylation | Affects phenotype | PMID:33476676 |
| GO:0072539 | T-helper 17 cell differentiation | Decreases phenotype | PMID:32911021 |
| GO:0072593 | Reactive oxygen species metabolic process | Increases phenotype | PMID:32023790; PMID:34474090; PMID:39736419 |
| GO:0097621 | Monoamine oxidase activity | Increases phenotype | PMID:39577800 |
| GO:0140042 | Lipid droplet formation | Increases phenotype | PMID:32220626; PMID:32763284; PMID:33865937; PMID:35736896; PMID:38685157; PMID:39778647 |
| GO:0140354 | Lipid import into cell | Increases phenotype | PMID:38388800 |
| GO:0160024 | Leydig cell proliferation | Affects phenotype | PMID:37601897 |
| GO:1900194 | Negative regulation of oocyte maturation | Increases phenotype | PMID:33476676 |
| GO:1900825 | Regulation of membrane depolarization during cardiac muscle cell action potential | Affects phenotype | PMID:38310357 |
| GO:1901275 | Tartrate metabolic process | Affects phenotype | PMID:38685157 |
| GO:1901670 | Negative regulation of superoxide dismutase activity | Increases phenotype | PMID:31875995 |
| GO:1901671 | Positive regulation of superoxide dismutase activity | Decreases phenotype | PMID:28259788 |
| GO:1901726 | Negative regulation of histone deacetylase activity | Increases phenotype | PMID:36534918 |
| GO:1901741 | Positive regulation of myoblast fusion | Increases phenotype | PMID:32750123 |
| GO:1901988 | Negative regulation of cell cycle phase transition | Increases phenotype | PMID:37717640 |
| GO:1903047 | Mitotic cell cycle process | Affects phenotype | PMID:31601247 |
| GO:1903283 | Negative regulation of glutathione peroxidase activity | Increases phenotype | PMID:31875995 |
| GO:1903284 | Positive regulation of glutathione peroxidase activity | Decreases phenotype | PMID:28259788 |
| GO:1903409 | Reactive oxygen species biosynthetic process | Increases phenotype | PMID:26916392; PMID:29102535; PMID:31453682 |
| GO:1903428 | Positive regulation of reactive oxygen species biosynthetic process | Increases phenotype | PMID:28259788; PMID:29940534; PMID:30195206; PMID:32023790; PMID:39059691 |
| GO:1903430 | Negative regulation of cell maturation | Increases phenotype | PMID:35803362 |
| GO:1903966 | Monounsaturated fatty acid biosynthetic process | Decreases phenotype | PMID:30145421; PMID:31453682 |
| GO:1904179 | Positive regulation of adipose tissue development | Increases phenotype | PMID:33755180 |
| GO:1990138 | Neuron projection extension | Decreases phenotype | PMID:31812737 |
| GO:1990375 | Baculum development | Affects phenotype | PMID:37164221 |
| GO:2000184 | Positive regulation of progesterone biosynthetic process | Increases phenotype | PMID:25576683 |
| GO:2000225 | Negative regulation of testosterone biosynthetic process | Increases phenotype | PMID:29940534; PMID:35803362 |
| GO:2000288 | Positive regulation of myoblast proliferation | Increases phenotype | PMID:32750123 |
| GO:2000469 | Negative regulation of peroxidase activity | Increases phenotype | PMID:29940534 |
| GO:2000611 | Positive regulation of thyroid hormone generation | Increases phenotype | PMID:30940137 |
| GO:2000833 | Positive regulation of steroid hormone secretion | Increases phenotype | PMID:37717640; PMID:38966215 |
| GO:2000835 | Negative regulation of androgen secretion | Increases phenotype | PMID:38966215 |
| GO:2000844 | Negative regulation of testosterone secretion | Increases phenotype | PMID:29940534; PMID:35803362 |
| GO:2000845 | Positive regulation of testosterone secretion | Increases phenotype | PMID:25576683; PMID:37837293 |
| GO:2000865 | Negative regulation of estradiol secretion | Increases phenotype | PMID:37837293 |
| GO:2000866 | Positive regulation of estradiol secretion | Increases phenotype | PMID:37717640 |
| GO:2000872 | Positive regulation of progesterone secretion | Increases phenotype | PMID:37717640 |
We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.